2818-07-7 Usage
Uses
Used in Pharmaceutical Industry:
DiMethyl 1H-pyrrole-2,4-dicarboxylate is utilized as a key intermediate in the synthesis of pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications, making it an essential component in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, DiMethyl 1H-pyrrole-2,4-dicarboxylate serves as a precursor for the creation of various agrochemicals. Its incorporation into these products can enhance their effectiveness in agricultural applications, such as pest control and crop protection.
Used in Research and Development:
DiMethyl 1H-pyrrole-2,4-dicarboxylate is also extensively used in research and development settings. Its reactivity and structural properties make it an ideal candidate for exploring new chemical reactions and syntheses, contributing to the advancement of organic chemistry and related fields.
Check Digit Verification of cas no
The CAS Registry Mumber 2818-07-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,1 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2818-07:
(6*2)+(5*8)+(4*1)+(3*8)+(2*0)+(1*7)=87
87 % 10 = 7
So 2818-07-7 is a valid CAS Registry Number.
2818-07-7Relevant articles and documents
JAK KINASE MODULATING COMPOUNDS AND METHODS OF USE THEREOF
-
Page/Page column 118-119, (2010/04/03)
Provided herein are pyrrolotriazine compounds for treatment of JAK kinase, including JAK2 kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonists
Meyers, Kenneth M.,Mendez-Andino, Jose,Colson, Anny-Odile,Hu, X. Eric,Wos, John A.,Mitchell, Maria C.,Hodge, Karen,Howard, Jeremy,Paris, Jennifer L.,Dowty, Martin E.,Obringer, Cindy M.,Reizes, Ofer
, p. 657 - 661 (2007/10/03)
The synthesis and biological testing of novel classes of potent melanin-concentrating hormone (MCH-R1) antagonists based on pyrazolopiperazinone and pyrrolopiperazinone scaffolds are described.